Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma

por Dupont, Thibault, Yang, ShaoNing, Patel, Jayeshkumar, Hatzi, Katerina, Malik, Alka, Tam, Wayne, Martin, Peter, Leonard, John, Melnick, Ari, Cerchietti, Leandro
Publicado 2015

Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas

por Cerchietti, Leandro, Damm-Welk, Christine, Vater, Inga, Klapper, Wolfram, Harder, Lana, Pott, Christiane, Yang, Shao Ning, Reiter, Alfred, Siebert, Reiner, Melnick, Ari, Woessmann, Willi
Publicado 2011

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients

por Pera, Benet, Tang, Tiffany, Marullo, Rossella, Yang, Shao-Ning, Ahn, Haelee, Patel, Jayeshkumar, Elstrom, Rebecca, Ruan, Jia, Furman, Richard, Leonard, John, Cerchietti, Leandro, Martin, Peter
Publicado 2016

A purine scaffold Hsp90 inhibitor destabilizes Bcl6 and has specific anti-tumor activity in Bcl6 dependent B-cell lymphomas

por Cerchietti, Leandro C, Lopes, Eloisi C, Yang, Shao Ning, Hatzi, Katerina, Bunting, Karen, Tsikitas, Lucas, Mallik, Alka, Robles, Ana I, Walling, Jennifer, Varticovski, Lyuba, Shaknovich, Rita, Bhalla, Kapil, Chiosis, Gabriela, Melnick, Ari M
Publicado 2009

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes

por Boi, Michela, Todaro, Maria, Vurchio, Valentina, Yang, Shao Ning, Moon, John, Kwee, Ivo, Rinaldi, Andrea, Pan, Heng, Crescenzo, Ramona, Cheng, Mangeng, Cerchietti, Leandro, Elemento, Olivier, Riveiro, Maria E., Cvitkovic, Esteban, Bertoni, Francesco, Inghirami, Giorgio
Publicado 2016

The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases

por Marullo, Rossella, Castro, Monica, Yomtoubian, Shira, Calvo-Vidal, M. Nieves, Revuelta, Maria Victoria, Krumsiek, Jan, Cho, Andrew, Morgado, Pablo Cresta, Yang, ShaoNing, Medina, Vanina, Roth, Berta M., Bonomi, Marcelo, Keshari, Kayvan R., Mittal, Vivek, Navigante, Alfredo, Cerchietti, Leandro
Publicado 2021

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

por Cayrol, Florencia, Praditsuktavorn, Pannee, Fernando, Tharu M., Kwiatkowski, Nicholas, Marullo, Rosella, Calvo-Vidal, M. Nieves, Phillip, Jude, Pera, Benet, Yang, Shao Ning, Takpradit, Kaipol, Roman, Lidia, Gaudiano, Marcello, Crescenzo, Ramona, Ruan, Jia, Inghirami, Giorgio, Zhang, Tinghu, Cremaschi, Graciela, Gray, Nathanael S., Cerchietti, Leandro
Publicado 2017

Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

por Cayrol, Florencia, Praditsuktavorn, Pannee, Fernando, Tharu M., Kwiatkowski, Nicholas, Marullo, Rossella, Calvo-Vidal, M. Nieves, Phillip, Jude, Pera, Benet, Yang, Shao Ning, Takpradit, Kaipol, Roman, Lidia, Gaudiano, Marcello, Crescenzo, Ramona, Ruan, Jia, Inghirami, Giorgio, Zhang, Tinghu, Cremaschi, Graciela, Gray, Nathanael S, Cerchietti, Leandro
Publicado 2017

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas

por Calvo-Vidal, M. Nieves, Zamponi, Nahuel, Krumsiek, Jan, Stockslager, Max A., Revuelta, Maria V., Phillip, Jude M., Marullo, Rossella, Tikhonova, Ekaterina, Kotlov, Nikita, Patel, Jayeshkumar, Yang, Shao Ning, Yang, Lucy, Taldone, Tony, Thieblemont, Catherine, Leonard, John P., Martin, Peter, Inghirami, Giorgio, Chiosis, Gabriela, Manalis, Scott R., Cerchietti, Leandro
Publicado 2021